Patents Assigned to ORASIS
  • Ophthalmic pharmaceutical compositions and uses relating thereto
    Patent number: 11974986
    Abstract: The disclosure relates to ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt. Aspects of the disclosure further relate to uses and preparations of ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt, for correcting presbyopia and other ocular conditions in a subject.
    Type: Grant
    Filed: July 27, 2021
    Date of Patent: May 7, 2024
    Assignee: Orasis Pharmaceuticals Ltd.
    Inventors: Claes Feinbaum, Franc Salamun, Sudhir Patel
  • Ophthalmic pharmaceutical compositions and uses relating thereto
    Patent number: 11129812
    Abstract: The disclosure relates to ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt. Aspects of the disclosure further relate to uses and preparations of ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt, for correcting presbyopia and other ocular conditions in a subject.
    Type: Grant
    Filed: March 26, 2020
    Date of Patent: September 28, 2021
    Assignee: ORASIS PHARMACEUTICALS LTD.
    Inventors: Claes Feinbaum, Franc Salamun, Sudhir Patel
  • Ophthalmic pharmaceutical compositions and uses relating thereto
    Patent number: 10639297
    Abstract: The disclosure relates to ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt. Aspects of the disclosure further relate to uses and preparations of ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt, for correcting presbyopia and other ocular conditions in a subject.
    Type: Grant
    Filed: July 10, 2018
    Date of Patent: May 5, 2020
    Assignee: Orasis Pharmaceuticals Ltd.
    Inventors: Claes Feinbaum, Franc Salamun, Sudhir Patel
  • Enhancement of aqueous flow
    Patent number: 10231871
    Abstract: Drainage of body fluid from an area of undesirably high pressure can be accomplished by interconnecting an artificial non-blood fluid conduit with the vascular system. For example, an artificial non-blood fluid conduit can be inserted into the eye to fluidly interconnect the anterior chamber with a location of lower pressure. The conduit can have a growth factor for stimulating growth of new blood vessels in the location of lower pressure to connect the new blood vessels with the non-blood fluid conduit.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: March 19, 2019
    Assignee: Orasis Medical, Inc.
    Inventor: Richard A. Hill
  • Ophthalmic pharmaceutical compositions and uses relating thereto
    Patent number: 9867810
    Abstract: The disclosure relates to ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt. Aspects of the disclosure further relate to uses and preparations of ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt, for correcting presbyopia and other ocular conditions in a subject.
    Type: Grant
    Filed: August 18, 2017
    Date of Patent: January 16, 2018
    Assignee: Orasis Pharmaceuticals Ltd.
    Inventors: Claes Feinbaum, Franc Salamun, Sudhir Patel
  • DRUG SCREENING METHOD, COMPOSITIONS AND METHODS OF TREATING GLAUCOMA
    Publication number: 20130316983
    Abstract: Methods are disclosed for treating glaucoma by treating a novel target. Methods for treating glaucoma by restoring the filtration capabilities of the endothelial lining of Schlemm's canal are provided. A method for identifying compounds capable of restoring the filtration capability of the juxtacanalicular meshwork is also provided.
    Type: Application
    Filed: May 3, 2013
    Publication date: November 28, 2013
    Applicant: ORASIS
    Inventor: ORASIS
  • COMPOSITIONS AND METHODS OF TREATING GLAUCOMA
    Publication number: 20130295075
    Abstract: Methods are disclosed for treating glaucoma by treating a novel target. Methods for treating glaucoma by restoring the filtration capabilities of the endothelial lining of Schlemm's canal are provided. A method for identifying compounds capable of restoring the filtration capability of the juxtacanalicular meshwork is also provided.
    Type: Application
    Filed: May 3, 2013
    Publication date: November 7, 2013
    Applicant: ORASIS
    Inventor: Richard A. Hill